CompletedEarly Phase 1NCT05017454

Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kasr El Aini Hospital
Principal Investigator
heba ahmed, Msc in dermatolo
Kasralainy Hospital, Faculty of Medicine, Cairo University
Intervention
the optimized sodium valproate-loaded nanospanlastic dispersion(drug)
Enrollment
67 target
Eligibility
12 years · All sexes
Timeline
20212023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05017454 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials